只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 2026-06-17 | ATEX Anterix Inc. | Guttman-McCabe Christopher Officer · Chief Reg & Comm Officer | 卖出（S） | 35,321 | US$81.32 | US$287.23万 | 133,923 | SEC |
| 2026-06-15 2026-06-17 | ATEX Anterix Inc. | Guttman-McCabe Christopher Officer · Chief Reg & Comm Officer | 卖出（S） | 26,411 | US$82.27 | US$217.28万 | 107,512 | SEC |
| 2026-06-15 2026-06-17 | ATEX Anterix Inc. | Guttman-McCabe Christopher Officer · Chief Reg & Comm Officer | 卖出（S） | 16,381 | US$83.72 | US$137.14万 | 91,131 | SEC |
| 2026-06-15 2026-06-17 | ATEX Anterix Inc. | Guttman-McCabe Christopher Officer · Chief Reg & Comm Officer | 卖出（S） | 13,324 | US$84.29 | US$112.31万 | 77,807 | SEC |
| 2026-06-12 2026-06-15 | GUTS FRACTYL HEALTH, INC. | Royan Ajay Director | 买入（P） | 23,000 | US$0.85 | US$19,550.00 | 40,901 | SEC |
| 2026-06-11 2026-06-12 | QURE uniQure N.V. | Gut Robert Director | 卖出（S） | 2,726 | US$27.06 | US$73,765.56 | 32,259 | SEC |
| 2026-06-10 2026-06-12 | QURE uniQure N.V. | Gut Robert Director | 卖出（S） | 2,645 | US$26.07 | US$68,955.15 | 32,342 | SEC |
| 2026-06-10 2026-06-12 | QURE uniQure N.V. | Gut Robert Director | 卖出（S） | 3,127 | US$26.03 | US$81,395.81 | 29,215 | SEC |
| 2026-06-10 2026-06-12 | QURE uniQure N.V. | Gut Robert Director | 卖出（S） | 1,780 | US$26.05 | US$46,369.00 | 27,435 | SEC |
| 2026-06-10 2026-06-12 | APMC AmperCap Acquisition Co | Gutierrez Pier Alberto Director,Officer,TenPercentOwner,Other · Co-CEO | 买入（P） | 34,912 | US$10.00 | US$349,120.00 | 3,914,079 | SEC |
| 2026-06-10 2026-06-11 | GUTS FRACTYL HEALTH, INC. | Rajagopalan Harith Director,Officer · Chief Executive Officer | 买入（P） | 25,000 | US$0.73 | US$18,250.00 | 540,557 | SEC |
| 2026-06-10 2026-06-11 | GUTS FRACTYL HEALTH, INC. | Sheffield Ian Director | 买入（P） | 35,000 | US$0.73 | US$25,550.00 | 35,000 | SEC |
| 2026-06-10 2026-06-11 | GUTS FRACTYL HEALTH, INC. | BRADLEY WILLIAM Director | 买入（P） | 68,493 | US$0.73 | US$49,999.89 | 84,622 | SEC |
| 2026-06-08 2026-06-09 | GUTS FRACTYL HEALTH, INC. | Smith Weber Lara Officer · Chief Financial Officer | 买入（P） | 20,000 | US$0.69 | US$13,800.00 | 20,000 | SEC |
| 2026-06-04 2026-06-12 | APMC AmperCap Acquisition Co | Gutierrez Pier Alberto Director,Officer,TenPercentOwner,Other · Co-CEO | 买入（P） | 247,500 | US$10.00 | US$247.5万 | 3,891,667 | SEC |
| 2026-06-04 2026-06-08 | APMC AmperCap Acquisition Co | Gutierrez Pier Alberto Director,Officer,TenPercentOwner · Co-CEO, Chairman | 买入（P） | 247,500 | US$10.00 | US$247.5万 | 247,500 | SEC |
| 2026-05-29 2026-06-01 | MCB Metropolitan Bank Holding Corp. | GUTMAN HARVEY Director | 卖出（S） | 3,000 | US$89.58 | US$268,740.00 | 18,243 | SEC |
| 2026-05-12 2026-05-15 | SBET Sharplink, Inc. | GUTKOWSKI ROBERT M Director | 卖出（S） | 12,892 | US$7.41 | US$95,529.72 | 24,998 | SEC |
| 2026-05-12 2026-05-13 | ANIP ANI PHARMACEUTICALS INC | Gutwerg Ori Officer · SVP, GENERICS | 卖出（S） | 2,772 | US$79.50 | US$220,374.00 | 78,696 | SEC |
| 2026-04-01 2026-04-06 | N/A Starwood Real Estate Income Trust, Inc. | Guttin Matthew S Officer · See Remarks | 卖出（S） | 3,256 | US$19.75 | US$64,306.00 | 35,062 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| GUTPC | 5,069 | 0 | 5,398.7019 | 93.89% | Q, N |
| GUTS | 234,297.1495 | 0 | 370,773.5247 | 63.19% | B, Q, N |
| GUT | 40,582.989 | 0 | 111,117.3589 | 36.52% | Q, N |